Literature DB >> 31215028

Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study.

Daniel Kapustin1,2, Jackie Leung1, Isaac Odame2, Suzan Williams3, Manohar Shroff4, Andrea Kassner1.   

Abstract

Sickle cell anaemia (SCA) is a devastating genetic blood disorder leading to chronic anaemia, impaired cerebrovascular dilatory capacity and cerebral infarctions. Our aim was to assess the relationship between microstructural properties of the white matter (WM) and both cerebrovascular reactivity (CVR) and cerebral blood flow, as well as the effects of hydroxycarbamide on these relationships. Our results demonstrate that mean CVR was increased in hydroxycarbamide-treated patients compared to untreated patients. Moreover, untreated SCA patients had increased skew and kurtosis of mean diffusivity histograms in the WM compared to hydroxycarbamide-treated patients and healthy age-matched controls, indicating disruption of WM integrity. Regression analysis of CVR and WM mean diffusivity (MD) revealed a significant linear relationship between CVR and MD histogram skew and kurtosis in healthy controls, but not in either of the two SCA groups. These findings suggest that patients treated with hydroxycarbamide possess white matter MD histogram parameters which more closely resemble those of healthy controls.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  hydroxycarbamide; magnetic resonance imaging; paediatrics; sickle cell anaemia

Year:  2019        PMID: 31215028     DOI: 10.1111/bjh.16063

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Hydroxycarbamide and white matter integrity in pediatric sickle cell disease: Commentary to accompany: Hydroxycarbamide treatment in children with sickle cell anaemia is associated with more intact white matter integrity: a quantitative MRI study.

Authors:  Eboni I Lance; Lori C Jordan
Journal:  Br J Haematol       Date:  2019-10       Impact factor: 6.998

2.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

3.  Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia.

Authors:  Hanne Stotesbury; Patrick W Hales; Melanie Koelbel; Anna M Hood; Jamie M Kawadler; Dawn E Saunders; Sati Sahota; David C Rees; Olu Wilkey; Mark Layton; Maria Pelidis; Baba Pd Inusa; Jo Howard; Subarna Chakravorty; Chris A Clark; Fenella J Kirkham
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-06       Impact factor: 6.960

4.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.